Key result
BP measurement inaccuracies drive persistent disparities in hypertension diagnosis and control.
Improving equity in hypertension management requires standardized measurement, access to appropriately sized validated devices, inclusive device validation, and reimbursement strategies that reach under-resourced communities.
Purpose of review We aimed to examine how inaccuracies and inequities in blood pressure (BP) measurement across office, ambulatory, home, and emerging cuffless modalities contribute to disparities in hypertension diagnosis and control, and to identify strategies to improve measurement equity. Recent findings Disparities arise from nonstandardized office technique, inappropriate cuff sizing, limited access to validated home and ambulatory devices, reimbursement and implementation barriers, and underrecognition of masked and nocturnal hypertension in populations at higher risk. Cuffless technologies may expand access and reduce cuff-related barriers, but current devices have important limitations in validation, calibration, real-world accuracy, and performance across diverse populations. Summary Improving equity requires standardized measurement, access to appropriately sized validated devices and out-of-office monitoring, inclusive device validation, and reimbursement and implementation strategies that reach underrepresented and under-resourced communities. Future research should test whether these approaches reduce diagnostic misclassification and improve BP control and cardiovascular outcomes across populations.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2026) conducted a review in Hypertension. Blood pressure measurement modalities was evaluated. Inaccuracies and inequities in blood pressure measurement across various modalities contribute to disparities in hypertension diagnosis and control, requiring standardized and inclusive validation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: